Literature DB >> 1372469

Xeroderma pigmentosum and Cockayne syndrome: overlapping clinical and biochemical phenotypes.

G A Greenhaw1, A Hebert, M E Duke-Woodside, I J Butler, J T Hecht, J E Cleaver, G H Thomas, W A Horton.   

Abstract

Two siblings are described whose clinical presentation of cutaneous photosensitivity and central nervous system dysfunction is strongly reminiscent of the DeSanctis-Cacchione syndrome (DCS) variant of xeroderma pigmentosum. An extensive clinical evaluation supported a diagnosis of DCS and documented previously unreported findings. In vitro fibroblast studies showed UV sensitivity that was two to three times that of normal controls. However, neither a post-UV-irradiation DNA excision-repair defect indicative of XP nor a semiconservative DNA replication defect indicative of XP variant was found. Rather, a failure of RNA synthesis to recover to normal levels after UV exposure was observed, a biochemical abnormality seen in Cockayne syndrome (CS), one of the premature-aging syndromes with clinical UV sensitivity. These patients, therefore, clinically have XP, but their biochemical characteristics suggest CS. The reason(s) for the severe neurologic disease, in light of the relatively mild cutaneous abnormalities, is unclear. Other cases with unusual fibroblast responses to irradiation have been noted in the literature and, along with the data from our patients, reinforce the notion of the complexity of DNA maintenance and repair.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372469      PMCID: PMC1682634     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

Review 1.  Diseases with DNA damage-processing defects.

Authors:  T L Timme; R E Moses
Journal:  Am J Med Sci       Date:  1988-01       Impact factor: 2.378

2.  Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair.

Authors:  J H Robbins; K H Kraemer; M A Lutzner; B W Festoff; H G Coon
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

3.  Xeroderma pigmentosum variants.

Authors:  J E Cleaver; A E Greene; L L Coriell; R A Mulivor
Journal:  Cytogenet Cell Genet       Date:  1981

4.  Increased UV resistance in xeroderma pigmentosum group A cells after transformation with a human genomic DNA clone.

Authors:  A Rinaldy; T Bellew; E Egli; R S Lloyd
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases.

Authors:  K H Kraemer; M M Lee; J Scotto
Journal:  Arch Dermatol       Date:  1987-02

6.  Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation.

Authors:  A D Andrews; S F Barrett; J H Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

7.  Primary segmental demyelination in the sural nerve in Cockayne's syndrome.

Authors:  A Ohnishi; A Mitsudome; Y Murai
Journal:  Muscle Nerve       Date:  1987-02       Impact factor: 3.217

8.  Relationship between pyrimidine dimers, 6-4 photoproducts, repair synthesis and cell survival: studies using cells from patients with trichothiodystrophy.

Authors:  B C Broughton; A R Lehmann; S A Harcourt; C F Arlett; A Sarasin; W J Kleijer; F A Beemer; R Nairn; D L Mitchell
Journal:  Mutat Res       Date:  1990-01       Impact factor: 2.433

9.  Peripheral neuropathy in four cases of group A xeroderma pigmentosum.

Authors:  N Tachi; K Sasaki; T Kusano; S Wakai; M Nagaoka; S Annaka; R Minami; S Imamura
Journal:  J Child Neurol       Date:  1988-04       Impact factor: 1.987

10.  Molecular cloning of a mouse DNA repair gene that complements the defect of group-A xeroderma pigmentosum.

Authors:  K Tanaka; I Satokata; Z Ogita; T Uchida; Y Okada
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

View more
  9 in total

Review 1.  Progeroid syndromes: probing the molecular basis of aging?

Authors:  D Kipling; R G Faragher
Journal:  Mol Pathol       Date:  1997-10

2.  Early postnatal ataxia and abnormal cerebellar development in mice lacking Xeroderma pigmentosum Group A and Cockayne syndrome Group B DNA repair genes.

Authors:  M Murai; Y Enokido; N Inamura; M Yoshino; Y Nakatsu; G T van der Horst; J H Hoeijmakers; K Tanaka; H Hatanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

Review 3.  The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum.

Authors:  P J Brooks
Journal:  Neuroscience       Date:  2006-12-19       Impact factor: 3.590

4.  Central nervous system dysmyelination in PIBI(D)S syndrome: a further case.

Authors:  P A Battistella; A Peserico
Journal:  Childs Nerv Syst       Date:  1996-02       Impact factor: 1.475

5.  Age-associated decreases in human DNA repair capacity: Implications for the skin.

Authors:  I M Hadshiew; M S Eller; B A Gilchrest
Journal:  Age (Omaha)       Date:  1999-04

6.  Cockayne syndrome complementation group B associated with xeroderma pigmentosum phenotype.

Authors:  T Itoh; J E Cleaver; M Yamaizumi
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

7.  UVs syndrome, a new general category of photosensitive disorder with defective DNA repair, is distinct from xeroderma pigmentosum variant and rodent complementation group I.

Authors:  T Itoh; Y Fujiwara; T Ono; M Yamaizumi
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

8.  An abundant evolutionarily conserved CSB-PiggyBac fusion protein expressed in Cockayne syndrome.

Authors:  John C Newman; Arnold D Bailey; Hua-Ying Fan; Thomas Pavelitz; Alan M Weiner
Journal:  PLoS Genet       Date:  2008-03-21       Impact factor: 5.917

Review 9.  Genetic correction of stem cells in the treatment of inherited diseases and focus on xeroderma pigmentosum.

Authors:  Sophie Rouanet; Emilie Warrick; Yannick Gache; Sabine Scarzello; Marie-Françoise Avril; Françoise Bernerd; Thierry Magnaldo
Journal:  Int J Mol Sci       Date:  2013-10-09       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.